Form 483

Mayo Clinic PET Radiochemistry Facility Form 483, 2015-12-04

FDA issued a Form 483 to Mayo Clinic PET Radiochemistry Facility on 2015-12-04 with 11 public-safe observations.

483· Form 483 issuedHuman Drugs11 observations

Mayo Clinic PET Radiochemistry Facility · Rochester, United States · Issued December 4, 2015

Overview

  • 11 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

4 Dec 2015
21 CFR 212.10

Lack Adequate Resources, Facilities, Equipment.

Cited by Scott T Ballard, Matthew R Maddox

4 Dec 2015
21 CFR 212.10

Lack Adequate Resources, Facilities, Equipment.

Cited by Scott T Ballard, Matthew R Maddox

4 Dec 2015
21 CFR 212.20(c)

Adverse effects of changes made

Cited by Scott T Ballard, Matthew R Maddox

4 Dec 2015
21 CFR 212.20(c)

Adverse effects of changes made

Cited by Scott T Ballard, Matthew R Maddox

4 Dec 2015
21 CFR 212.50(a)

Written control procedures

Cited by Scott T Ballard, Matthew R Maddox

Inspected site

MCMayo Clinic PET Radiochemistry FacilityRochester, United States

Inspection team

MRMatthew R Maddox

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 212.60(g)(3)Cited across public-safe Form 483 observations3x
21 CFR 212.10Cited across public-safe Form 483 observations2x
21 CFR 212.20(c)Cited across public-safe Form 483 observations2x
21 CFR 212.50(a)Cited across public-safe Form 483 observations2x
21 CFR 212.71(b)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 11 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere